Nigeria Takes Lessons From Past Outbreaks to Contain Coronavirus
Nigeria's experience battling infectious diseases including cholera and Ebola may have better equipped Africa's most populous country from in dealing with the rapidly spreading coronavirus than some of its peers.
A network of laboratories used to identify sufferers of other illnesses have been made available to help contain the new virus, which has killed more than 3,000 people around the world, according to Michael Ryan, executive director for the WHO's Health Emergencies Programme.
“Nigeria has well-tested mechanisms for dealing with these dangerous pathogens,” Ryan told reporters. “The same labs which can do influenza diagnostics can now transfer and do COVID-19 diagnostics,” he said, using the formal title of the disease.
Nigeria confirmed the first case in sub-Saharan Africa on Feb. 27, but no more yet been reported. The victim is an Italian man who had traveled on business to Lagos from Milan, and health authorities got in touch with over 100 people who may have come into contact with him and asked them to remain in self-isolation.
The number of Nigerian laboratories to help early detection has tripled since 2014, when the country was part of the effort to end an Ebola outbreak that eventually killed 11,000 people across three nations, Chikwe Ihekweazu, director of Nigeria Centre for Disease Control (NCDC), said in an emailed response to questions.
--With assistance from William Clowes.
To contact the reporter on this story: Ruth Olurounbi in Abuja at rolurounbi4@bloomberg.net
To contact the editors responsible for this story: Anthony Osae-Brown at aosaebrown2@bloomberg.net, John Bowker, Hilton Shone
©2020 Bloomberg L.P.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.